相关实验视频
Updated: May 3, 2026

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
3.5K
一种不受控制的1型糖尿病患者的哈曼综合征:一个病例报告
Asahi Ishihara1,2, Katsuyuki Sagishima1, Tadashi Ejima1
1Department of Critical Care Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.
JA clinical reports
|May 17, 2025
概括
这种病例研究呈现了哈曼综合征,这是一种罕见的自发性肺中枢性病症,与糖尿病酸性脂肪酸症 (DKA) 相关. 早期识别和文化敏感的护理对国际患者至关重要.
科学领域:
- 内部医学 内部医学
- 肺部病理学 肺部病理学
- 内分泌学 在内分泌学.
背景情况:
- 哈曼综合征涉及到自发的肺中.
- 糖尿病酸性酸症 (DKA) 是一种严重的糖尿病并发症.
- 该案将哈曼综合征与外国国民的DKA联系在一起.
研究的目的:
- 报告一个罕见的哈曼综合征病例.
- 为了突出其与糖尿病酸性脂肪酸症的关联.
- 强调需要有文化能力的护理.
主要方法:
- 一名20岁的男性出现了恶心和呼吸困难.
- 诊断成像 (CT扫描) 证实了肺中.
- 实验室测试显示高血糖症,代谢性酸和高水平,表明DKA.
主要成果:
- 这位患者被诊断出患有DKA的二次哈曼综合征.
- 通过内镜检查,没有发现胃肠道穿孔.
- 用胰岛素和液体进行保守的管理导致了恢复.
结论:
- 哈曼综合征可能发生在患有DKA的患者中.
- 及时诊断和治疗至关重要.
- 对国际居民来说,文化敏感的医疗保健至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Hyperosmolar Hyperglycemic State
20
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
20

